Holen Sie sich die Stockscreener-App
5.7654
0.35%
0.0154
Schlusskurs vom Vortag:
$5.75
Offen:
$5.68
24-Stunden-Volumen:
484.64K
Relative Volume:
0.19
Marktkapitalisierung:
$938.48M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-206.69M
KGV:
-4.2533
EPS:
-1.3555
Netto-Cashflow:
$-186.49M
1W Leistung:
-5.41%
1M Leistung:
+4.91%
6M Leistung:
+87.34%
1J Leistung:
+192.89%
1-Tages-Spanne:
$5.65
$5.92
1-Wochen-Bereich:
$5.65
$6.26
52-Wochen-Spanne:
$1.60
$7.18
Annexon Inc Stock (ANNX) Company Profile
Firmenname
Annexon Inc
Sektor
Branche
Telefon
(650) 822-5500
Adresse
1400 SIERRA POINT PARKWAY, BRISBANE
Compare ANNX vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ANNX
Annexon Inc
|
5.775 | 934.42M | 0 | -206.69M | -186.49M | -1.3555 |
VRTX
Vertex Pharmaceuticals Inc
|
426.25 | 107.83B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
709.03 | 73.54B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
801.11 | 48.72B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
294.67 | 39.51B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
298.01 | 32.66B | 5.36B | 287.73M | 924.18M | 2.5229 |
Annexon Inc Stock (ANNX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-23 | Eingeleitet | Chardan Capital Markets | Buy |
| 2024-03-01 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-12-21 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-10-30 | Eingeleitet | Wells Fargo | Overweight |
| 2023-05-26 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-05-25 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-09-16 | Eingeleitet | Jefferies | Buy |
| 2022-09-09 | Eingeleitet | BTIG Research | Buy |
| 2021-11-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-09-23 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-01-26 | Eingeleitet | Needham | Buy |
| 2020-08-18 | Eingeleitet | BofA Securities | Buy |
| 2020-08-18 | Eingeleitet | Cowen | Outperform |
| 2020-08-18 | Eingeleitet | JP Morgan | Overweight |
Alle ansehen
Annexon Inc Aktie (ANNX) Neueste Nachrichten
Wall Street analysts see a 165.52% upside in Annexon (ANNX): Can the stock really move this high? - MSN
ANNX: Late-stage C1q inhibitors show strong efficacy in GBS and GA, with pivotal data due in 2026 - TradingView
Annexon (NASDAQ: ANNX) proxy asks approval to boost share authorization and elect directors - Stock Titan
Annexon stock rises after director purchases shares - MSN
Annexon presents four studies on Guillain-Barre syndrome disease burden and targeted therapies - Traders Union
ANNX Earnings History & Surprises | EPS & Revenue Results | ANNEXON INC (NASDAQ:ANNX) - ChartMill
Annexon (ANNX): 7 Small Cap Stocks with the Highest Upside Potential - Insider Monkey
Annexon Biosciences Stock Surges 289 Percent Amid Clinical Progress - HarianBasis.co
Annexon Biosciences (ANNX) Buy Rating Retained - Insider Monkey
Annexon, Inc. (NASDAQ:ANNX) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Does Annexon’s 2026 “Win Year” Milestone Roadmap Reshape The Bull Case For Annexon (ANNX)? - simplywall.st
Analysts Offer Insights on Healthcare Companies: Danaher (DHR), Annexon Biosciences (ANNX) and UnitedHealth (UNH) - The Globe and Mail
Annexon (NASDAQ: ANNX) seeks vote to increase authorized shares to 500M - Stock Titan
Needham Maintains Annexon(ANNX.US) With Buy Rating, Maintains Target Price $11 - Moomoo
Annexon CEO Touts “Win Year” 2026 at Needham, Eyes GA Phase III Data and GBS FDA Filing - Yahoo Finance
Annexon (NASDAQ:ANNX) Trading 8.5% Higher Following Insider Buying Activity - MarketBeat
Carson buys $49k in Annexon (ANNX) stock - Investing.com
Insider Buying: Annexon (NASDAQ:ANNX) Director Purchases 8,000 Shares of Stock - MarketBeat
Carson buys $49k in Annexon (ANNX) stock By Investing.com - Investing.com India
Annexon (NASDAQ: ANNX) director adds 8,000 shares in planned stock purchase - Stock Titan
EV Market: Will Annexon Inc benefit from government policyWall Street Watch & Technical Buy Zone Confirmation - baoquankhu1.vn
Annexon (NASDAQ:ANNX) Shares Down 6.1%Here's Why - MarketBeat
Is Annexon (ANNX) Stock Undervalued Now | ANNX Q4 Earnings: Beats Estimates by $0.04PEG Ratio - Cổng thông tin điện tử tỉnh Lào Cai
Macro Review: Will Annexon Inc benefit from government policyPortfolio Gains Summary & Real-Time Volume Analysis Alerts - baoquankhu1.vn
Annexon to Present at the 25th Annual Needham Virtual Healthcare Conference - Bitget
Geopolitics Watch: What are the risks of holding Annexon Inc2026 Analyst Calls & Long-Term Investment Growth Plans - baoquankhu1.vn
Annexon (NASDAQ:ANNX) Shares Up 6.6%What's Next? - MarketBeat
HC Wainwright Estimates Annexon FY2030 Earnings - MarketBeat
Annexon posts full-year 2025 financial results and portfolio updates - Traders Union
H.C. Wainwright Maintains Annexon(ANNX.US) With Buy Rating, Maintains Target Price $14 - Moomoo
Dip Buying: Can Annexon Inc reach all time highs this yearTrade Exit Report & Stepwise Trade Signal Implementation - baoquankhu1.vn
Is Annexon (NASDAQ:ANNX) In A Good Position To Deliver On Growth Plans? - Sahm
Finanzdaten der Annexon Inc-Aktie (ANNX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.83%
2.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):